Journals / Akademik Acil Tıp Dergisi / 2012 / Cilt: 11 - Sayı: 1

Valproik asit kullanan bir hamilede sağ atriyumdaki mobil trombusun neden olduğu masif pulmoner emboli

Massive pulmonary embolism with mobile right atrial thrombus in a pregnant patient using valproic acid

Pages
52–54
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The baby was completely healthy without any problem or deformity. (JAEM 2012; 11: 52-4)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary embolism is a life threatening condition.
📊
Key Findings & Data:The present case report describes successful treatment of a massive pulmonary embolism with tissue plasminogen activator (t-PA), caused by a mobile right atrial thrombus in a 30-year-old first trimester pregnant women using valproic acid.
💡
Conclusion & Impact:The baby was completely healthy without any problem or deformity. (JAEM 2012; 11: 52-4)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Pulmonary embolism is a life threatening condition. Pregnancy is among the risk factors of pulmonary embolism. There is reluctance about using thrombolytics s during pregnancy due to potential teratogenic effects. Valproic acid is one of the most commonly used antiepileptic agents, hovewer, its use during pregnancy is controversial because of the teratogenic potential. Among adverse effects of valproic acid use, elevated liver enzymes, thrombocytopenia have been reported. Moreover, product literature warns that pregnant women using valproic acid should be monitored for low fibrinogen and platelets and the potential for bleeding. The present case report describes successful treatment of a massive pulmonary embolism with tissue plasminogen activator (t-PA), caused by a mobile right atrial thrombus in a 30-year-old first trimester pregnant women using valproic acid. This has not been reported previously. During follow-ups, she was free of any signs or symptoms and gave birth to a baby by spontaneous vaginal delivery. The baby was completely healthy without any problem or deformity. (JAEM 2012; 11: 52-4)

Özet

Pulmoner emboli hayatı tehdit eden bir durumdur. Hamilelik pulmoner emboli için risk faktörleri arasındadır. Potansiyel teratojenik etkilerinden dolayı hamilelikte trombolitik kullanımında çekince vardır. Valproik asit, en çok kullanılan antiepileptik ilaçlardan olmakla beraber, teratojenik potansiyelinden dolayı hamilelikte kullanımı tartışmalıdır. Valproik asit kullanımının yan etkileri arasında karaciğer enzimlerinde artış ve trombositopeni bildirilmiştir. Üstelik, ürün bilgisi hamilelikte valproik asit kullanımı sırasında hastanın düşük fibrinojen ve trombosit seviyeleri ile kanama riski nedeniyle monitorize edilmesi konusunda uyarıda bulunmaktadır. Bu vaka takdimi valproik asit kullanan 30 yaşında ve ilk trimesterdeki bir hamilede sağ atriyumdaki mobil trombusun neden olduğu masif pulmoner embolinin doku plazminojen aktivatörü ile başarılı bir şekilde tedavi edildiğinden bahsetmektedir ve daha önce bildirilmemiştir. Takiplerde hastanın herhangi bir semptom ve bulgusu olmadı ve spontan vajinal doğum ile bir bebek dünyaya getirdi. Bebek tamamen sağlıklıydı ve herhangi bir problemi veya deformitesi mevcut değildi. (JAEM 2012; 11: 52-4)

🔖

Cite This Article

AKÇAY, M., YÜCE, M., ENDER, H. S., SARI, E., YAVUZ, S., YİĞİTER, R., SARI, İ., DAVUTOĞLU, V. (2022). Valproik asit kullanan bir hamilede sağ atriyumdaki mobil trombusun neden olduğu masif pulmoner emboli. Akademik Acil Tıp Dergisi, Cilt: 11 - Sayı: 1, 52–54. https://ajindex.com/articles/431681

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chan L, Cutler A. Thrombolytic therapy and prophylactic anticoagulation in pregnant patients. Am J Emerg Med 1999
  2. [CrossRef] 2. Huang SL, Chien CH, Chang YC. A floating thrombus of the right ventricle in severe massive pulmonary embolism. Am J Emerg Med 2008
  3. [CrossRef] 3. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999
  4. [CrossRef] 4. Torbicki A, Tramarin R, Morpurgo M. Role of echo/Doppler in the diagnosis of pulmonary embolism. Clin Cardiol 1992
  5. [CrossRef] 5. Kasper W, Geibel A, Tiede N, Bassenge D, Kauder E, Konstantinides S, et al. Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography. Br Heart J 1993
  6. [CrossRef] 6. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 2000
  7. [CrossRef] 7. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch Intern Med 2002
  8. [CrossRef] 8. Flossdorf T, Breulmann M, Hopf HB. Successful treatment of massive pulmonary embolism with recombinant tissue type plasminogen activator (rt-PA) in a pregnant woman with intact gravidity and preterm labour. Intensive Care Med 1990
  9. [CrossRef] 9. Patel RK, Fasan O, Arya R. Thrombolysis in pregnancy. Thromb Haemost 2003
  10. Seifried E, Gabelmann A, Ellbruck D, Schmidt A. Thrombolytic therapy of pulmonary artery embolism in early pregnancy with recombinant tissuetype plasminogen activator. Geburtshilfe Frauenheilkd 1991
  11. [CrossRef] 11. Yap LB, Alp NJ, Forfar JC. Thrombolysis for acute massive pulmonary embolism during pregnancy. Int J Cardiol 2002
  12. [CrossRef] 12. Sofocleous CT, Hinrichs C, Bahramipour P, Barone A, Abujudeh H, Contractor D. Percutaneous management of lifethreatening pulmonary embolism complicating early pregnancy. J Vasc Interv Radiol 2001
  13. [CrossRef] 13. Baudo F, Caimi TM, Redaelli R, Nosari AM, Mauri M, Leonardi G, et al. Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism in a pregnant woman with antithrombin III deficiency. Am J Obstet Gynecol 1990
  14. Leonhardt G, G